Neuro
Neuro
Transition to Addiction
Addiction
Addiction
100

Mesolimbic pathway is known as the

final common pathway for reward pleasure and please seeking

100

Drugs of addiction have different structures  and NTs targets in the brain but they all exhibit?

Acute reward- extreme euphoria

chronic reward- euphoria, but not excited

sensitization- of receptors with drug use

negative withdrawal symptoms

associative cue learning- ppl, places, and things)

incentive motivation-relapse

(impulsivity ------>compulsivity = Addiction to Abuse)

100

Stages of addiction? 

May start as voluntary  but for addicts no loner a choice

pleasure received from various stages of the brain's natural reward system promotes continued use

repeated exposure to drugs induces the brain's mechanism (need drug to avoid withdrawal=dependence)

dependence leads to daily use to avoid unpleasant sxm of withdrawal

prolonged use leads to brain changes (may be irreversible) that may underlie compulsive drug seeking behavior and consequences which is addiction

100

Role of PFC

regulates judgement planning and executive fxn

send inhibitory signals to the VTA DA neurons in the mesolimbic reward pathway  overcome impulse of instant gratification

100

Addiction is about _________ & __________

behaviors & consequences

200

It starts at the VTA and ends up at the?

Nucleus Accumbens

200

All drugs mimic  the brains NTs examples?


other drugs can stimulant, block, and reuptake. to be  a drug of abuse it has to mimic NTs

ETOH-Gaba

Cannabis- cannabinoids

Opiates- mu opiate

Nicotine- Acetylcholine

Hallucinogens- 5HT

ETOH/PCP- glutamate

200

Dependence is _____ in DSM


Ecstasy ______ away receptors, classified as a _________ but is  ___________ drug hitting multiple areas of the brain

not


burns, hallucinogen, behavioral

200

in the Cognitive change model, stimulant drug  users damage the ___________ ________ that carries the inhibitory signals from the PFC to the MLRPW

Chronic ETOH uses have ______ GABA which is used to signal the MLRPW to release _________

Opiates damage the _______ ___ _____ itself

frontalstriatal loop


Low, DA

PFC

200

Essential Features of SUD

cluster of behavioral, cognitive, and physiological symptoms indicating an individual continues use despite significant substance related problems

change in brain circuits may persist beyond detoxification with pts with severe disorders

300

The mesolimbic pathway depolarizes and releases_______ and we feel contentment

Dopamine

300

Which drugs bypasses the VTA and goes straight to the Nucleus Accumbens? 


What is the most addicting drug?

Cocaine, Amphetamines. psychostimulants


work in reverse of SSRIs. they cause reuptake mechanism to spin in the opposite direction which causes an increase release of DA. causing a rapid flooding of DA. 

that's why crack is snorted goes directly in the blood stream and bypasses the blood brain barrier. 


Cocaine

300

What are the biological models of addiction?

Change Set point Model - 

Cognitive Deficits Model

300

Stress can ________ drug levels in addicts

Rationale:

trigger

abuse drugs raises the level of cortisol which plays a primary role in stress response

cortisol raises the level of active in the MLRW system

attributes to the abuser to take drugs in the 1st place and continued usage



300

SUD Criteria 

4 patterns of behaviors

Risky use-physically hazardous

Impaired control- larger amts over longer period of time

Pharmaogical criteria- tolerance withdrawal

Social impairment-unable to fulfil work/home duties



400

Dopamine is ________ 1st then experience __________

released

pleasure

400

When nicotine hits the __________ receptors  _______ it 

When other drugs of abuse hit the receptors they _________ it

chain smokers acetylcholine continues too? 

Acetylcholine , desensitizes 


stimulate ( wears off in 2-4 hours)

stimulate

400

Explain Change set Model


not sure if current page 5

drug alters biological or psychological settings or baseline. Variant #1  drugs tell brain to stop making/storing/releasing DA in the VTA after pleasurable activities=no happiness d/t decreases 5HT and INREASED NE in th locus Corelus= withdrawal

Variant #2 DA becomes dysfunctional INCREASING glutamate. continued drug use = increase autoreceptors shutdown DA leaving it depleted leads to withdrawal

Variant #3 sensitivity to environmental cues. during times when drug is not available brain remembers the drug =cravings ( increased glutamate and NE)



 NTs act alone

400

Tolerance:


Withdrawal:

Person need more an more of the drug to get the same euphoria

predictable cluster of s/s following an abrupt discontinuation or rapid decrease in intake a a drug that has been used continuously over a period of time

substances in a similar pharmacological class produce similar withdrawal sxm


withdrawal also depends on the point of entry

400

________   ___ _________is the process of which a substance on which an individual is physically dependent is gradually eliminated from body 

Goals of this process (3)

Management of withdrawal


safe, humane, and prepare for ongoing tx (need therapist to start the process

(federal government)

500

All drugs of abuse end up at the VTA except ?

whenever a drug of abuse is used in the beginning  DA is produced how many times then nahual  concentration? 

Cocaine


10-100 Xs

500

Drugs were discovered ________ NTs

They look at  the _________ manifestation of drugs

before

behavioral 

500

Types of cravings?

Cue based- response to environmental stimuli most notable with cocaine & nicotine(external give Buprenorphine)


State or stress based: arises out of stress emotional tone (ETOH & Sedatives d/t anxiety)give Acamprosate

Opiates have both Cue and state cravings

500

Behavioral Criteria for Substance Use Disorder

A problematic pattern of substance use leading to clinically significant impairment or distress as manifested 2 out of 11 criteria manifested occurring in the same 12 month period


Severity of addition depends on how many criteria are met

500

Withdrawal initial assessment includes

evaluation of predicted withdrawal severity

medical comorbidity

psychiatric comorbidity